Riju Ray, Ph.D. - Publications

2007 University of Pennsylvania, Philadelphia, PA, United States 
Pharmacology, Public Health

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Dubroff JG, Doot RK, Falcone M, Schnoll RA, Ray R, Tyndale RF, Brody AL, Hou C, Schmitz A, Lerman C. Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 1724-9. PMID 26272810 DOI: 10.2967/jnumed.115.155002  0.36
2013 Loughead J, Ray R, Wileyto EP, Ruparel K, O'Donnell GP, Senecal N, Siegel S, Gur RC, Lerman C. Brain activity and emotional processing in smokers treated with varenicline. Addiction Biology. 18: 732-8. PMID 21507156 DOI: 10.1111/j.1369-1600.2011.00324.x  0.36
2012 Ashare RL, Ray R, Lerman C, Strasser AA. Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: a pilot feasibility study. Drug and Alcohol Dependence. 126: 263-7. PMID 22595038 DOI: 10.1016/j.drugalcdep.2012.04.019  0.36
2012 Lee W, Ray R, Bergen AW, Swan GE, Thomas P, Tyndale RF, Benowitz NL, Lerman C, Conti DV. DRD1 associations with smoking abstinence across slow and normal nicotine metabolizers. Pharmacogenetics and Genomics. 22: 551-4. PMID 22495174 DOI: 10.1097/FPC.0b013e3283539062  0.36
2012 Falcone M, Gold AB, Wileyto EP, Ray R, Ruparel K, Newberg A, Dubroff J, Logan J, Zubieta JK, Blendy JA, Lerman C. μ-Opioid receptor availability in the amygdala is associated with smoking for negative affect relief. Psychopharmacology. 222: 701-8. PMID 22389047 DOI: 10.1007/s00213-012-2673-5  0.36
2011 Ray R, Ruparel K, Newberg A, Wileyto EP, Loughead JW, Divgi C, Blendy JA, Logan J, Zubieta JK, Lerman C. Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. Proceedings of the National Academy of Sciences of the United States of America. 108: 9268-73. PMID 21576462 DOI: 10.1073/pnas.1018699108  0.36
2011 Falcone M, Jepson C, Benowitz N, Bergen AW, Pinto A, Wileyto EP, Baldwin D, Tyndale RF, Lerman C, Ray R. Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 13: 498-503. PMID 21385908 DOI: 10.1093/ntr/ntr012  0.36
2010 Wei J, Ma JZ, Payne TJ, Cui W, Ray R, Mitra N, Lerman C, Li MD. Replication and extension of association of choline acetyltransferase with nicotine dependence in European and African American smokers. Human Genetics. 127: 691-8. PMID 20383528 DOI: 10.1007/s00439-010-0818-3  0.36
2010 Loughead J, Ray R, Wileyto EP, Ruparel K, Sanborn P, Siegel S, Gur RC, Lerman C. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biological Psychiatry. 67: 715-21. PMID 20207347 DOI: 10.1016/j.biopsych.2010.01.016  0.36
2010 Ray R, Mitra N, Baldwin D, Guo M, Patterson F, Heitjan DF, Jepson C, Wileyto EP, Wei J, Payne T, Ma JZ, Li MD, Lerman C. Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1374-82. PMID 20147892 DOI: 10.1038/npp.2010.7  0.36
2009 Ray R, Schnoll RA, Lerman C. Nicotine dependence: biology, behavior, and treatment. Annual Review of Medicine. 60: 247-60. PMID 19630572 DOI: 10.1146/annurev.med.60.041707.160511  0.36
2009 Newberg AB, Ray R, Scheuermann J, Wintering N, Saffer J, Schmitz A, Freifelder R, Karp J, Lerman C, Divgi C. Dosimetry of 11C-carfentanil, a micro-opioid receptor imaging agent. Nuclear Medicine Communications. 30: 314-8. PMID 19242386 DOI: 10.1097/MNM.0b013e328329a0ec  0.36
2009 Ray R, Tyndale RF, Lerman C. Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes. Journal of Neurogenetics. 23: 252-61. PMID 19169923 DOI: 10.1080/01677060802572887  0.36
2008 Ray R, Loughead J, Wang Z, Detre J, Yang E, Gur R, Lerman C. Neuroimaging, genetics and the treatment of nicotine addiction Behavioural Brain Research. 193: 159-169. PMID 18599130 DOI: 10.1016/j.bbr.2008.05.021  0.36
2008 Wang Z, Ray R, Faith M, Tang K, Wileyto EP, Detre JA, Lerman C. Nicotine abstinence-induced cerebral blood flow changes by genotype. Neuroscience Letters. 438: 275-80. PMID 18499348 DOI: 10.1016/j.neulet.2008.04.084  0.36
2008 Heitjan DF, Asch DA, Ray R, Rukstalis M, Patterson F, Lerman C. Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment Pharmacogenomics Journal. 8: 391-399. PMID 18347612 DOI: 10.1038/sj.tpj.6500492  0.36
2008 Heitjan DF, Guo M, Ray R, Wileyto EP, Epstein LH, Lerman C. Identification of pharmacogenetic markers in smoking cessation therapy. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 147: 712-9. PMID 18165968 DOI: 10.1002/ajmg.b.30669  0.36
2007 Phillips JM, Siegel SJ, Shields AE, Patterson F, Gould TJ, Strasser AA, Ray R, Pinto A, Audrain-McGovern J, Rukstalis M, Perkins KA, Blendy JA, Lerman C. Translating basic science to improve pharmacotherapy for nicotine dependence. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 9: S583-98. PMID 18067034 DOI: 10.1080/14622200701691755  0.36
2007 Ray R, Jepson C, Wileyto EP, Dahl JP, Patterson F, Rukstalis M, Pinto A, Berrettini W, Lerman C. Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 9: 1237-41. PMID 17978999 DOI: 10.1080/14622200701648367  0.36
2007 Ray R, Schnoll RA, Lerman C. Pharmacogenetics and smoking cessation with nicotine replacement therapy. Cns Drugs. 21: 525-33. PMID 17579497  0.36
2006 Dahl JP, Cubells JF, Ray R, Weller AE, Lohoff FW, Ferraro TN, Oslin DW, Kampman KM, Dackis C, Tang Y, Gelernter J, Kranzler HR, O'Brien CP, Berrettini WH. Analysis of variations in the tryptophan hydroxylase-2 (TPH2) gene in cocaine dependence. Addiction Biology. 11: 76-83. PMID 16759340 DOI: 10.1111/j.1369-1600.2006.00005.x  0.36
2005 Ray R, Doyle GA, Crowley JJ, Buono RJ, Oslin DW, Patkar AA, Mannelli P, DeMaria PA, O'Brien CP, Berrettini WH. A functional prodynorphin promoter polymorphism and opioid dependence. Psychiatric Genetics. 15: 295-8. PMID 16314761 DOI: 10.1097/00041444-200512000-00013  0.36
Show low-probability matches.